Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma × Diagnostic Imaging × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 8 Lung Neoplasms 4 Prostatic Neoplasms 3 Barrett Esophagus 3 Recurrence 2 Neoplasms 2 Multiple Pulmonary Nodules 2 Melanoma 2 Glioma 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Spinal Fractures 1 Solitary Pulmonary Nodule 1 Smoking Cessation 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Rectal Neoplasms 1 Phyllodes Tumor 1 Pancreatic Neoplasms 1 Osteoporosis 1 Nevus 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 Lung Diseases 1 Liver Cirrhosis 1

Interventions

Oxaliplatin 42 Gemcitabine 41 Fluorouracil 37 pembrolizumab 29 Capecitabine 29 Leucovorin 26 Docetaxel 25 Cisplatin 24 Paclitaxel 21 Carboplatin 18 Bevacizumab 17 Irinotecan 16 130-nm albumin-bound paclitaxel 16 Radiotherapy 15 Pemetrexed 15 Nivolumab 13 Albumin-Bound Paclitaxel 13 Cyclophosphamide 10 Ramucirumab 9 zolbetuximab 7 Trastuzumab 7 Radiosurgery 7 Drug Therapy 7 trastuzumab deruxtecan 6 cemiplimab 6 Taxes 6 Erlotinib Hydrochloride 6 Blood Specimen Collection 6 durvalumab 5 Sorafenib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00795184 2016-05-03

DONTBIOPCE

Mauna Kea Technologies

Phase NA Completed

122 enrolled 5 charts

Gastrointestinal

Adenocarcinoma, Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡